218 related articles for article (PubMed ID: 21106879)
1. Analysis of agonist and antagonist effects on thyroid hormone receptor conformation by hydrogen/deuterium exchange.
Figueira AC; Saidemberg DM; Souza PC; Martínez L; Scanlan TS; Baxter JD; Skaf MS; Palma MS; Webb P; Polikarpov I
Mol Endocrinol; 2011 Jan; 25(1):15-31. PubMed ID: 21106879
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors.
Martínez L; Sonoda MT; Webb P; Baxter JD; Skaf MS; Polikarpov I
Biophys J; 2005 Sep; 89(3):2011-23. PubMed ID: 15980170
[TBL] [Abstract][Full Text] [Related]
3. Dynamics and ligand-induced solvent accessibility changes in human retinoid X receptor homodimer determined by hydrogen deuterium exchange and mass spectrometry.
Yan X; Broderick D; Leid ME; Schimerlik MI; Deinzer ML
Biochemistry; 2004 Feb; 43(4):909-17. PubMed ID: 14744134
[TBL] [Abstract][Full Text] [Related]
4. Identification of a new hormone-binding site on the surface of thyroid hormone receptor.
Souza PC; Puhl AC; Martínez L; Aparício R; Nascimento AS; Figueira AC; Nguyen P; Webb P; Skaf MS; Polikarpov I
Mol Endocrinol; 2014 Apr; 28(4):534-45. PubMed ID: 24552590
[TBL] [Abstract][Full Text] [Related]
5. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
7. Low-resolution structures of thyroid hormone receptor dimers and tetramers in solution.
Figueira AC; Neto Mde O; Bernardes A; Dias SM; Craievich AF; Baxter JD; Webb P; Polikarpov I
Biochemistry; 2007 Feb; 46(5):1273-83. PubMed ID: 17260956
[TBL] [Abstract][Full Text] [Related]
8. Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.
Martínez L; Polikarpov I; Skaf MS
J Phys Chem B; 2008 Aug; 112(34):10741-51. PubMed ID: 18681473
[TBL] [Abstract][Full Text] [Related]
9. Design of thyroid hormone receptor antagonists from first principles.
Webb P; Nguyen NH; Chiellini G; Yoshihara HA; Cunha Lima ST; Apriletti JW; Ribeiro RC; Marimuthu A; West BL; Goede P; Mellstrom K; Nilsson S; Kushner PJ; Fletterick RJ; Scanlan TS; Baxter JD
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):59-73. PubMed ID: 12650702
[TBL] [Abstract][Full Text] [Related]
10. Ligand-induced conformational changes in the acetylcholine-binding protein analyzed by hydrogen-deuterium exchange mass spectrometry.
Shi J; Koeppe JR; Komives EA; Taylor P
J Biol Chem; 2006 Apr; 281(17):12170-7. PubMed ID: 16484218
[TBL] [Abstract][Full Text] [Related]
11. Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone.
Yang L; Broderick D; Jiang Y; Hsu V; Maier CS
Biochim Biophys Acta; 2014 Sep; 1844(9):1684-93. PubMed ID: 24953769
[TBL] [Abstract][Full Text] [Related]
12. Analysis of ligand binding and protein dynamics of human retinoid X receptor alpha ligand-binding domain by nuclear magnetic resonance.
Lu J; Cistola DP; Li E
Biochemistry; 2006 Feb; 45(6):1629-39. PubMed ID: 16460010
[TBL] [Abstract][Full Text] [Related]
13. Molecular and structural biology of thyroid hormone receptors.
Apriletti JW; Ribeiro RC; Wagner RL; Feng W; Webb P; Kushner PJ; West BL; Nilsson S; Scanlan TS; Fletterick RJ; Baxter JD
Clin Exp Pharmacol Physiol Suppl; 1998 Nov; 25():S2-11. PubMed ID: 9809185
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling revealed that ligand dissociation from thyroid hormone receptors is affected by receptor heterodimerization.
Zhuang S; Bao L; Linhananta A; Liu W
J Mol Graph Model; 2013 Jul; 44():155-60. PubMed ID: 23831995
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
[TBL] [Abstract][Full Text] [Related]
16. X-ray crystallographic and functional studies of thyroid hormone receptor.
Ribeiro RC; Apriletti JW; Wagner RL; Feng W; Kushner PJ; Nilsson S; Scanlan TS; West BL; Fletterick RJ; Baxter JD
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):133-41. PubMed ID: 9699866
[TBL] [Abstract][Full Text] [Related]
17. On the denaturation mechanisms of the ligand binding domain of thyroid hormone receptors.
Martínez L; Souza PC; Garcia W; Batista FA; Portugal RV; Nascimento AS; Nakahira M; Lima LM; Polikarpov I; Skaf MS
J Phys Chem B; 2010 Jan; 114(3):1529-40. PubMed ID: 20043653
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
19. Thyroxine-thyroid hormone receptor interactions.
Sandler B; Webb P; Apriletti JW; Huber BR; Togashi M; Cunha Lima ST; Juric S; Nilsson S; Wagner R; Fletterick RJ; Baxter JD
J Biol Chem; 2004 Dec; 279(53):55801-8. PubMed ID: 15466465
[TBL] [Abstract][Full Text] [Related]
20. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
